Press Room

Find news and updates from PhRMA, representing the country’s leading biopharmaceutical research companies. Our members are committed to finding tomorrow’s cures and treatments for some of the most serious diseases such as cancer, Alzheimer’s disease, cystic fibrosis and Parkinson’s.

Latest News from PhRMA

PhRMA Statement on Part D Provision in Budget Deal

February 8, 2018

Today, PhRMA President and CEO Stephen J. Ubl provided the following statement:

Read More

Amgen CEO Robert A. Bradway Becomes PhRMA Board Chairman

February 7, 2018

The Pharmaceutical Research and Manufacturers of America (PhRMA) held its board meeting today, officially welcoming three new elected officers. Robert A. Bradway, chairman and CEO, Amgen, became chairman of the PhRMA board of directors

Read More

PhRMA Statement on HELP ACT

January 17, 2018

Today, Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Stephen J. Ubl provided the following statement.

Read More

PhRMA Statement on Comments to CMS Regarding Proposed Part D Rule and RFI Exploring Pass-Through Rebates to Seniors at Point of Sale

January 16, 2018

Today, the Pharmaceutical Research and Manufacturers of America (PhRMA) submitted comments to the Centers for Medicare & Medicaid Services regarding the proposed rule, “Contract Year 2019 Policy and Technical Changes to the Medicare Advantage Medicare Cost Plan, Medicare Fee-for-Service, the Medicare Prescription Drug Benefit Programs, and the PACE Program.”

Read More

PhRMA Statement on 340B PAUSE Act

December 21, 2017

The legislation introduced today by Representatives Larry Bucshon and Scott Peters is yet another important action taken this year to begin to address the problems in the 340B program.

Read More

PhRMA Announces Major Commitment to Address the Opioid Crisis in America

December 12, 2017

PhRMA announced a new multi-year, multimillion dollar initiative to address the opioid crisis, which will include a partnership with the Addiction Policy Forum to fund state and local programs, as well as support for new public policies that help families and individuals impacted by the crisis.

Read More

PhRMA Challenges Unconstitutional Provisions of California’s SB 17 in Federal Court

December 8, 2017

Today, PhRMA initiated litigation in the United States District Court for the Eastern District of California challenging SB 17, an unprecedented and unconstitutional California law.

Read More

New Report Shows How Supply Chain Shapes Brand-Name Medicine Prices

November 29, 2017

A new report from PhRMA is among the first to examine how money flows through the supply chain system – which includes wholesalers, pharmacy benefit managers (PBMs), pharmacies and insurers – and how that impacts what patients pay at the pharmacy.

Read More

PhRMA Statement on Report President Commissions’ Final Report with Opioid Recommendations

November 2, 2017

PhRMA is working with the (NIH) and NIDA to establish a public-private partnership that will advance the development of non-addictive pain treatment options.

Read More

Leading Biopharmaceutical Researchers to Showcase the New Era of Medicine on Capitol Hill

November 2, 2017

PhRMA is bringing more than 50 scientists and researchers from America’s biopharmaceutical companies to meet with policymakers and senior staff today on Capitol Hill.

Read More